Prevalence of hemolysis and metabolic acidosis in patients with circulatory failure supported with extracorporeal life support: a marker for survival?

scientific article published in May 2017

Prevalence of hemolysis and metabolic acidosis in patients with circulatory failure supported with extracorporeal life support: a marker for survival? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/EJHF.854
P698PubMed publication ID28470926

P50authorAlois PhilippQ121097853
Matthias LubnowQ121097856
P2093author name stringThomas Müller
Florian Zeman
Christof Schmid
Karla Lehle
York Zausig
Dirk Lunz
Maik Foltan
P2860cites workAssessment of outcome after severe brain damageQ34216702
Serum neuron specific enolase - impact of storage and measuring methodQ34438865
Technical complications during veno-venous extracorporeal membrane oxygenation and their relevance predicting a system-exchange--retrospective analysis of 265 casesQ34611276
Low-pH association of proteins with the membranes of intact red blood cells. II. Studies of the mechanismQ35197676
Free radical metabolism in human erythrocytesQ37074963
Management of the post-cardiac arrest syndromeQ37979015
Erythrocytic system under the influence of physical exercise and trainingQ37988701
Acute myocardial infarction and cardiogenic shock: pharmacologic and mechanical hemodynamic support pathwaysQ38476470
Metabolic and electrolyte disturbance after cardiac arrest: How to deal with it.Q38670235
Comparing extracorporeal cardiopulmonary resuscitation with conventional cardiopulmonary resuscitation: A meta-analysisQ38724696
Extracorporeal Life Support for Cardiopulmonary Resuscitation for Adults: Evolving EvidenceQ38902907
Anemia during hard physical training (sports anemia) and its causal mechanism with special reference to protein nutrition.Q40286771
Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patientsQ40335196
Outcome predictors in cardiopulmonary resuscitation facilitated by extracorporeal membrane oxygenationQ40612197
Clinical course and long-term outcome following venoarterial extracorporeal life support-facilitated interhospital transfer of patients with circulatory failureQ40861046
Flow dynamics of different adult ECMO systems: a clinical evaluationQ45059151
The impact of severe acidemia on neurologic outcome of cardiac arrest survivors undergoing therapeutic hypothermia.Q45145878
Hemolysis and ECMO pumps in the 21st CenturyQ48722306
European Resuscitation Council and European Society of Intensive Care Medicine 2015 guidelines for post-resuscitation care.Q48933108
A comparison study of haemolysis production in three contemporary centrifugal pumps.Q50481209
A 5-year experience with cardiopulmonary resuscitation using extracorporeal life support in non-postcardiotomy patients with cardiac arrest.Q64991867
Foot Impact Force and Intravascular Hemolysis During Distance RunningQ68347357
Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysisQ70590520
Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulationQ73632997
Hemolytic characteristics of three commercially available centrifugal blood pumpsQ81182252
Assessment of outcomes and differences between in- and out-of-hospital cardiac arrest patients treated with cardiopulmonary resuscitation using extracorporeal life supportQ84565306
Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial)Q85675841
[Veno-arterial extracorporeal membrane oxygenation. Indications, limitations and practical implementation]Q87468128
P921main subjectextracorporeal membrane oxygenationQ1385195
metabolic acidosisQ1598200
P304page(s)110-116
P577publication date2017-05-01
P1433published inEuropean Journal of Heart FailureQ5017954
P1476titlePrevalence of hemolysis and metabolic acidosis in patients with circulatory failure supported with extracorporeal life support: a marker for survival?
P478volume19 Suppl 2